Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Clin Rheumatol

Search In Journal Title:

Abbravation: Clinical Rheumatology

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1016/0020-7683(86)90112-5

Search In DOI:

ISSN

1434-9949

Search In ISSN:
Search In Title Of Papers:

Osteoarthritis of the hip or knee which coexistin

Authors: Kerstin G Reeuwijk Mariëtte de Rooij Gabriella M van Dijk Cindy Veenhof Martijn P Steultjens Joost Dekker
Publish Date: 2010/02/23
Volume: 29, Issue: 7, Pages: 739-747
PDF Link

Abstract

Exercise therapy is generally recommended in osteoarthritis OA of the hip or knee However coexisting disorders may bring additional impairments which may necessitate adaptations to exercise for OA of the hip or knee For the purpose of developing an adapted protocol for exercise therapy in OA patients with coexisting disorders information is needed on which specific coexisting disorders in OA are associated with activity limitations and pain To describe the relationship between specific coexisting disorders activity limitations and pain in patients with OA of the hip or knee a crosssectional cohort study among 288 older adults 50–85 years of age with OA of hip or knee was conducted Subjects were recruited from three rehabilitation centers and two hospitals Demographic data clinical data information about coexisting disorders ie comorbidity and other disorders activity limitations WOMAC physical functioning domain and pain visual analogue scale VAS were collected by questionnaire Statistical analysis included descriptive statistics and multivariate regression analysis Coexisting disorders associated with activity limitations were chronic back pain or hernia arthritis of the hand or feet and other chronic rheumatic diseases all musculoskeletal disorders diabetes and chronic cystitis nonmusculoskeletal disorders hearing impairments in a facetoface conversation vision impairments in long distances and dizziness in combination with falling all sensory impairments and overweight and obesity Coexistent disorders associated with pain were arthritis of the hand or feet other chronic rheumatic diseases musculoskeletal disorders and diabetes nonmusculoskeletal disorder Specific disorders coexisting next to OA and associated with additional activity limitations and pain were identified These coexisting disorders need to be addressed in exercise therapy and rehabilitation for patients with OA of the hip or kneeOsteoarthritis OA is one of the diseases with the highest rates of comorbidity 1 Previous studies have reported comorbidity rates of 68 to 85 2 3 4 5 Diseases that frequently occur next to OA are diabetes hypertension and cardiovascular disorders other disorders including overweight and back pain occur frequently as well 1 4 6 Thus coexisting disorders—defined as coexisting diseases and coexisting other disorders eg overweight—are highly prevalent in OAExercise therapy is generally recommended in OA of the hip or knee Exercise is effective in reducing activity limitations and pain in OA 7 8 However coexisting disorders may bring additional impairments which necessitate adaptations to the exercise protocol for OA of the hip or knee For the future purpose of developing such an adapted protocol information is needed on which specific coexisting disorders in OA are disabling ie which coexisting disorders are associated with activity limitations and pain Coexisting disorders causing activity limitations and pain are likely to cause restrictions to exercise therapy as well necessitating adaptations in the exercise protocolPreviously we have reported which coexisting disorders are associated with additional activity limitations and pain in OA of hip or knee 5 9 In these studies we used the Cumulative Illness Rating Scale CIRS 10 11 12 to assess coexisting disorders The CIRS yields information on global categories of coexisting diseases eg ear eye nose and throat diseases or endocrine and metabolic diseases Although quite informative more detailed information on which specific coexisting disorders are disabling is required in order to be able to develop the exercise therapy protocol with adaptations for coexisting disorders The objective of the study was to describe the relationship between specific coexisting disorders activity limitations and pain in patients with hip or knee OAThe present study is a secondary analysis of previously reported data 5 The design of this crosssectional study is summarized below The reader is referred to the original publication for a more detailed description of the design 5 The study was approved by the Medical Ethical Committee of the VU University Medical Centre Amsterdam the NetherlandsParticipants were recruited from three rehabilitation centers and two hospitals Departments of Orthopedics Rheumatology or Rehabilitation Inclusion criteria were a diagnosis of OA of the hip or knee by medical specialist according to radiological criteria or clinical criteria of the American College of Rheumatology 13 14 b 50 years of age or older c referral to hospital or rehabilitation center less than a year before inclusion d at least moderate functional problems Lequesne algofunctional index score ≥5 15 and e informed consent Exclusion criteria were a 85 years of age or older b insufficient understanding of the Dutch language and c expected death due to fatal illness within 1 year after inclusionPatients were invited to a test location The data used in the present study were gathered by means of interview demographic and clinical data and questionnaires activity limitations pain and coexistent disorders Xrays were used to evaluate radiological impairment of the hip or knee


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima–media in patients with systemic autoimmune diseases
  2. The virtuoso foot
  3. Responsiveness of the DASH score in surgically treated basal joint arthritis of the thumb: preliminary results
  4. RAPID3 scores and hand outcome measurements in RA patients: a preliminary study
  5. Bone mineral density in children with familial Mediterranean fever
  6. Chorea as a side effect of gabapentin (Neurontin®) in a patient with complex regional pain syndrome Type 1
  7. Risk factors in transient osteoporosis: a retrospective study on 23 cases
  8. Outcome of reactive arthritis after an extensive Finnish waterborne gastroenteritis outbreak: a 1-year prospective follow-up study
  9. Elevated serum TRAIL levels in scleroderma patients and its possible association with pulmonary involvement
  10. The autonomic nervous system in systemic sclerosis. A review
  11. Detection of anticardiolipin antibody IgG by time-resolved fluoroimmunoassay
  12. Prescription patterns and trends in anti-rheumatic drug use based on a large-scale claims database in Japan
  13. Rheumatoid arthritis: should we shift the focus from “Treat to Target” to “Treat to Work?”
  14. Intercellular adhesion molecules in systemic lupus erythematosus patients with lupus nephritis
  15. Severe deficiency of 25-hydroxyvitamin D 3 (25-OH-D 3 ) is associated with high disease activity of rheumatoid arthritis
  16. The expression of death decoy receptor 3 was increased in the patients with primary Sjögren’s syndrome
  17. Prognostic factors in a cohort of antisynthetase syndrome (ASS): serologic profile is associated with mortality in patients with interstitial lung disease (ILD)
  18. Tuberculosis infection in patients with systemic lupus erythematosus: pulmonary and extra-pulmonary infection compared
  19. Prolonged infections associated with antineutrophil cytoplasmic antibodies specific to proteinase 3 and myeloperoxidase: diagnostic and therapeutic challenge
  20. Group visits for rheumatoid arthritis patients: a pilot study
  21. Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis
  22. The impact of current health-related quality of life on future health outlook in patients with eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome)
  23. Two cases demonstrating thalidomide’s efficacy in refractory lupus nephritis
  24. Rheumatoid arthritis among Nigerians: the first 200 patients from a rheumatology clinic
  25. The challenge of profound hypoglycorrhachia: two cases of sarcoidosis and review of the literature
  26. Chronic intestinal pseudo-obstruction in patients with systemic lupus erythematosus: report of four cases
  27. Relationship of Q angle and joint hypermobility and Q angle values in different positions
  28. Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels
  29. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease
  30. Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
  31. Oxidative status in rheumatoid arthritis
  32. Impact and therapy of osteoarthritis: the Arthritis Care OA Nation 2012 survey
  33. Follicular bronchiolitis, an unusual cause of haemoptysis in giant cell arteritis
  34. Treatment of acute neuropsychiatric lupus with intravenous immunoglobulin (IVIG): a case report and review of the literature
  35. Vitamin D and systemic lupus erythematosus: state of the art
  36. Challenges and opportunities for diagnosis and treatment of rheumatoid arthritis in Latin America
  37. Clostridium difficile : an under-recognized cause of reactive arthritis?
  38. Prevalence of rheumatic diseases in Raramuri people in Chihuahua, Mexico: a community-based study
  39. Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis
  40. A systematic review of homoeopathy for the treatment of fibromyalgia
  41. Do hip OA patients referred to orthopedic surgeons by general practitioners and rheumatologists differ?
  42. The pathway of estradiol-induced apoptosis in patients with systemic lupus erythematosus
  43. Antistreptococcal Response is Exaggerated in Children with Familial Mediterranean Fever
  44. High rate of disease remission in moderate rheumatoid arthritis on etanercept therapy: data from GISEA, the Italian biologics register
  45. Beware of the biologicals—hospitals may die: the Rheumatism Foundation Hospital, Heinola, Finland (1951–2010)
  46. Patterns of pain in Paget’s disease of bone and their outcomes on treatment with pamidronate
  47. QT dispersion in uncomplicated familial Mediterranean fever
  48. Ultrasonographic evaluation of the muscle architecture in patients with systemic lupus erythematosus
  49. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin
  50. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis
  51. Autonomic dysfunction in psoriatic arthritis
  52. Exercise therapy for patients with diffuse idiopathic skeletal hyperostosis
  53. Reproducibility of the Bath Ankylosing Spondylitis Indices of disease activity (BASDAI), functional status (BASFI) and overall well-being (BAS-G) in anti-tumour necrosis factor-treated spondyloarthropathy patients
  54. The changes in monosaccharide composition of immunoglobulin G in the course of rheumatoid arthritis
  55. Increased expression of IL - 28RA mRNA in peripheral blood mononuclear cells from patients with systemic lupus erythematosus
  56. Contrast-enhanced power Doppler sonography of knee synovitis in rheumatoid arthritis: assessment of therapeutic response
  57. Long-term follow-up of autologous stem cell transplantation for severe paediatric systemic lupus erythematosus
  58. Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome
  59. Neridronate and human osteoblasts in normal, osteoporotic and osteoarthritic subjects
  60. Evaluation of a mail-delivered, print-format, self-management program for persons with systemic sclerosis
  61. Serum galectin-3 level in systemic sclerosis
  62. Non-rheumatoid erosive arthritis associated with type I hereditary angioedema
  63. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
  64. Familial Mediterranean fever responds well to infliximab: single case experience
  65. Prevalence of soluble peptidylarginine deiminase 4 (PAD4) and anti-PAD4 antibodies in autoimmune diseases
  66. The role of PET/CT in Cogan’s syndrome
  67. Treatment of osteoporosis in renal insufficiency
  68. STAT4 rs7574865 G/T polymorphism is associated with rheumatoid arthritis and disease activity, but not with anti-CCP antibody levels in a Mexican population

Search Result: